Skip to main content
Twitter
LinkedIn
Email
About
Company
Hydrogel Technology
History
Leadership
Clinical Trials
Contact Us
Pipeline
Retinal Diseases
OTX-TKI (axitinib intravitreal implant)
OTX-AFS (aflibercept suprachoroidal injection)
Glaucoma
OTX-TIC (travoprost intracameral implant)
Dry Eye Disease
OTX-CSI (cyclosporine intracanalicular insert)
OTX-DED (episodic dry eye disease)
Products
DEXTENZA
®
ReSure
®
Sealant
Investors
SEC Filings
Corporate Governance
Board of Directors
Committee Composition
Stock Information
Analyst Coverage
Historical Price Lookup
Investment Calculator
Press Releases
Calendar of Events
Corporate Presentation
Investor FAQs
Information Request
Careers
Culture and Values
Benefits
Open Positions
Search
Site Map
Site Map
Ocular Therapeutix
About
Company
Hydrogel Technology
History
Leadership
Contact Us
Company TEST
Research
Pipeline
OTX-TIC (travoprost intracameral implant)
OTX-AFS (aflibercept suprachoroidal injection)
OTX-TKI (axitinib intravitreal implant)
Clinical Trials
OTX-CSI (cyclosporine intracanalicular insert)
OTX-DED (episodic dry eye disease)
Products
DEXTENZA
®
ReSure
®
Sealant
Investors
Careers
Core Values + Benefits
Benefits
Company Culture and Values
Search
Privacy Policy
Terms and Conditions of Use
We use cookies to ensure that we give you the best experience on our website. By using this website you agree to the
Privacy Policy
and
Terms of Use
.
Accept
